Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Genes|September 28, 2021
Multi-Dimensional Scaling Analysis of Key Regulatory Genes in Prostate Cancer Using the TCGA DatabaseLaura Boldrini, Pinuccia Faviana, Luca Galli, et al.
Biomedical Engineering Online|August 18, 2009
Definition of an automated Content-Based Image Retrieval (CBIR) system for the comparison of dermoscopic images of pigmented skin lesionsAlfonso Baldi, Raffaele Murace, Emanuele Dragonetti, et al.
Tumori|July 31, 2014
Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case reportElisa Biasco, Andrea Antonuzzo, Claudia Cianci, et al.
Tumori|June 14, 2018
A case of a patient with severe renal failure on hemodialysis treated with vismodegib for relapsing basal cell carcinomaAndrea Sbrana, Andrea Antonuzzo, Luca Galli, et al.
Future Oncology (London, England)|December 25, 2019
Dedifferentiated liposarcoma: when eribulin can make the differenceAndrea Sbrana, Federico Paolieri, Francesco Bloise, et al.
Medical Oncology (Northwood, London, England)|May 13, 2024
Tumor microenvironment and clinical efficacy of first line immunotherapy-based combinations in metastatic renal cell carcinomaEnrico Sammarco, Martina Rossetti, Alessia Salfi, et al.
Pathogens (Basel, Switzerland)|January 28, 2026
Prevention of Transfusion-Transmitted Malaria and Chagas Disease in Non-Endemic Countries: An 8-Year Study of Seroprevalence Among Donors at Risk in Tuscany (Central Italy)Valentina D Mangano, Barbara Pinto, Roberto Marotta, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 1, 2018
EZH2 Expression in Intestinal Neuroendocrine TumorsPinuccia Faviana, Riccardo Marconcini, Sergio Ricci, et al.
Experimental Hematology & Oncology|March 28, 2017
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 monthsRiccardo Marconcini, Luca Galli, Andrea Antonuzzo, et al.
Immunotherapy|March 28, 2025
Incidence and impact of immune combination therapies adverse events in advanced renal cell carcinoma patientsMartina Catalano, Giulia Venturi, Alessia Salfi, et al.
Pageof 15